Skip to content
TELEHEALTHSEO

GEO FOR DERMATOLOGY BRANDS

SEO for Teledermatology and Prescription Skincare Brands

A category where the ingredient outranks the brand, and the buyer researches the molecule before they choose the seller. Built for eight and nine figure brands.

Ingredient-Led
We map molecules to intent
MD-Reviewed
Before publication
From $7,995/mo
Fully managed

See where your ingredient authority is weakest

Start with your domain. We will show you which actives your competitors own and which are still open.

Step 1 of 5

What is your website?

Your domain is enough.

SEO for dermatology brands is search optimisation for teledermatology platforms and prescription skincare companies. Demand in this category is ingredient-led rather than brand-led, meaning buyers research active compounds such as tretinoin before choosing a supplier, which shapes the entire content architecture.

17
exits, all built on organic search
$150M
revenue generated for clients
35+
team members worldwide
100%
hands-off, fully managed

What this looks like when it works

Every figure below is from live client work. Brand names are withheld at client request; we walk through the accounts, dashboards and timelines live on the call.

All case studies
  • Top 3

    for "buy mounjaro" in the UK

    Top 3 for the most contested term in UK weight loss

  • $550k

    organic revenue in 2.5 months

    A research-use-only peptide brand, $550k from organic

  • 19.32x

    ROSI in 90 days

    An organic revenue engine built in a single quarter

01

The ingredient outranks the brand

This is the defining characteristic of dermatology search and it separates the category from almost everything else in telehealth.

The ingredient outranks the brand
KeywordVolumeDifficultyCPC
tretinoin255,00068$2.00
online dermatologist6,30044$4.00
prescription acne treatment20034$2.00

"tretinoin" does 255,000 searches a month. "online dermatologist", the query that describes what you actually sell, does 6,300. The ingredient outranks the service by a factor of forty.

That asymmetry dictates the strategy. Your buyer is not searching for a teledermatology platform. They are researching a molecule, forming a view about whether it suits them, and only then looking for somewhere to get it. A content architecture built around your service offering misses the first two steps of that journey entirely, which is where the decision is actually made.

The brands winning this category built ingredient authority first and converted it into service demand second.

02

Tretinoin, and the actives around it

Tretinoin carries the category. It is a topical retinoid, prescription-only in most markets, with an established evidence base for acne and photoaging and a well-documented adjustment period that generates enormous search demand on its own.

That adjustment period is the content opportunity most brands underuse. "tretinoin purging", strength progression, application frequency and irritation management are all high-intent queries from people who have already started treatment and are deciding whether to continue. Retaining an existing customer through week six is worth more than acquiring a new one, and the content that does it also ranks.

Around tretinoin sit the adjacent actives: clindamycin and benzoyl peroxide in combination therapy, azelaic acid for rosacea and melasma, hydroquinone with its own regulatory complications, and isotretinoin, which sits behind iPLEDGE requirements in the US and cannot be marketed as though it were accessible on the same terms as the rest.

03

A visual category with a compliance problem

Dermatology is inherently visual and the imagery is where compliance goes wrong.

Before and after photography without disclosed treatment duration, concurrent treatments or lighting consistency is the most common failure. Skin type representation is another: content and imagery built around a narrow range of skin tones both underserves a large part of the market and reads as a quality problem to evaluators.

There is also a real difference between cosmetic claims and medical ones. "Reduces the appearance of fine lines" and "treats photoaging" are not interchangeable phrases, and which one you can use depends on the product's regulatory status rather than on which sounds better.

04

Competing with Curology, Apostrophe and the publishers

You have two different competitive sets and they need different responses.

On ingredient head terms, you are competing with Healthline, the American Academy of Dermatology and Mayo Clinic. Those are not winnable directly and pursuing them wastes budget.

On commercial and comparison terms you are competing with Curology and Apostrophe, and that is a real fight but a fair one. Their exposure is the same as every scaled DTC brand: content written for the widest possible audience, leaving gaps on specific conditions, specific skin types and specific stages of treatment. That is where we start.

Here is what happens if nothing changes

  1. 01

    Ingredient authority takes time to build

    The brands that own tretinoin content today started years ago. So does the one that owns it in three years.

  2. 02

    Retention content is being written by competitors

    The customer deciding whether to push through week six is reading someone's content. It should be yours.

  3. 03

    Your blended CAC keeps climbing

    Paid drives 27% of web traffic against organic's 53%, and a quarter of users block ads entirely.

  4. 04

    Paid never becomes an asset

    It does not compound and it does not transfer at exit.

When I am asked if I know of anyone in the SEO space, without hesitation I point them to DTC SEO. They truly understand the power of authority content, onsite metrics, and strategic backlinking and has the network to put it into play.
Amanda Raab, Mergers & Acquisitions, Quiet Light Brokerage

Links we have landed for clients

  • Forbes
  • TIME
  • Cosmopolitan
  • Men's Health
  • Inc
  • Martha Stewart
  • Time Out
  • Apartment Therapy
  • mindbodygreen
  • well+good
  • OK!
  • Best

Your buyer researches the molecule first

Tell us where you are and we will map the ingredient demand that converts into service demand.

Step 1 of 5

What is your website?

Your domain is enough.

What we deploy for dermatology brands

  • AI Search and GEO

    Getting cited inside ChatGPT, Perplexity and AI Overviews, and an honest account of what that is currently worth.

  • Doctor-Reviewed Content

    Expert writers produce it. A licensed physician signs off on clinical accuracy before it goes live. In YMYL categories that step is not optional.

  • Digital PR

    We connect your business to a credentialed expert and place their commentary in publications with real editorial standards. Their credibility becomes yours.

  • Link Building

    Health publishers vet harder and charge more, which is why most agencies avoid the category and why links remain the largest ranking lever in it.

  • Technical SEO

    Regulated catalogues accumulate structural problems general ecommerce sites never encounter. Most of the fix is consolidation rather than creation.

  • Programmatic SEO

    Location and variant pages at scale, built as data rather than as templates, so they inform rather than duplicate.

Dermatology SEO: what founders ask us

Why does ingredient content matter more than service content?

Because that is where the decision happens. "tretinoin" does 255,000 monthly searches against 6,300 for "online dermatologist". Buyers research the molecule, form a view, and only then look for a supplier. Service-led architecture misses the first two steps.

Can we rank for "tretinoin"?

The head term is difficulty 68 against Healthline, the AAD and Mayo Clinic, so not directly. The long tail around it, covering purging, strength progression, application frequency and irritation management, is winnable and converts far better.

How should we handle before and after imagery?

With disclosed treatment duration, any concurrent treatments, and consistent lighting. Undisclosed context is the most common compliance failure in the category and it is also a visible quality signal to evaluators.

Can we market isotretinoin the same way as other actives?

No. Isotretinoin sits behind iPLEDGE requirements in the US and cannot be presented as accessible on the same terms as topical treatments. Content that implies otherwise is a compliance exposure.

What is the difference between a cosmetic and a medical claim?

"Reduces the appearance of fine lines" is cosmetic. "Treats photoaging" is medical. Which one you can use depends on the product's regulatory status, not on which reads better.

What does dermatology SEO cost?

Fully managed engagements start at $7,995 per month. Building ingredient authority is a content-heavy programme, so scope typically sits above the entry point.

For dermatology brands doing $10M+

One call. Your actives, your claim exposure, and the fastest path to a lower blended CAC.

Step 1 of 5

What is your website?

Your domain is enough.

For brands doing $10M+